Innovation Pharmaceuticals Inc (IPIX)

[Gratefullife]

Beth Israel, not Cellceutix, reported the first time ever tumor shrinkage for notoriously intractable renal cancer, in vivo and in combination with a Pfizer drug.

I believe it unlikely Beth Israel would do so if the amount of remission were, by extrapolation, insignificant re. the health of a cancer patient.

If it were certain Kevetrin works as well in humans as it has in the preclinical testing (which has been independently verified) CTIX market cap would be far higher.

I expect that to be the case, eventually.

Dr. Menon has stellar credentials; this has been well-established